MTOR and osteosarcoma: Recent advancements in genetic and molecular research have elucidated critical pathways involved in osteosarcoma pathogenesis, such as the PI3K/Akt/mTOR axis, VEGF-mediated angiogenesis, and PD-1/PD-L1 signaling.